about
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...
Read More
1.36
0.02
(1.49%)
717.7K
XNAS Volume
XNAS 21 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
InflaRx NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..